Emerging anticoagulant and thrombolytic drugs

Author： Iqbal O.   Aziz S.   Hoppensteadt D.A.   Ahmad S.   Walenga J.M.   Bakhos M.   Fareed J.  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.6, Iss.1, 2001-04, pp. : 111-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IBC’s 11th Annual International Symposium: Advances in Anticoagulant, Antithrombotic and Thrombolytic Drugs

By Mousa S.A.   Fareed J.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 1, 2001-01 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Hypersensitivity Reactions to Anticoagulant Drugs

By  

Current Pharmaceutical Design, Vol. 14, Iss. 27, 2008-09 ,pp. : 2863-2873

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Anticoagulant Drugs: A Historical Perspective

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 83-104

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs for focal epilepsy

By Mula Marco  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 87-95

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for neuroblastoma

By Castel Victoria  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 155-171

Informa Healthcare

Access to resources Recommend Favorite